Yatsen Group, the parent company of leading Chinese beauty brands, including Perfect Diary and Dr. Wu, recently released its Beauty Innovation Insights in Shanghai.

Centered on innovation, the book presents a systematic overview of the group's achievements across six key areas, including global R&D strategy, technological breakthroughs, efficacy validation, and sustainability. It marks a milestone in the company's efforts to elevate its beauty science on the global stage, the company said.

"This launch is both a summary of our R&D accumulation in recent years and a platform for open dialogue with the industry and society,"Huang Jinfeng, founder, chairman, and CEO of Yatsen Group, said. "It reflects our long-term commitment to global R&D, global talent, and global markets."

The Chinese version launch follows the group's release of the English edition at the 35th IFSCC Congress in August, where Yatsen became the first Chinese beauty company to present its R&D framework and achievements internationally.

At that event, the group showcased Dr. Wu's breakthrough PDRN Hydrating Essence, featuring a bioactive ingredient used in aesthetic medicine to deliver professional-level hydration results through topical application.

The company's innovation model integrates industry, academia, medical research, and fundamental science, with artificial intelligence enhancing efficiency and precision. This "closed-loop" innovation ecosystem, according to the company, enables faster breakthroughs and sets a replicable model for the broader Chinese beauty industry.

Among the highlights detailed, is Perfect Diary's advancement in "integrated skincare and makeup". In collaboration with the China Association of Fragrance, Flavor and Cosmetic Industries and Shanghai Ruijin Hospital, Perfect Diary launched the industry's first Integrated Skincare and Makeup Report and introduced the third-generation of Biotec's bionic film technology.

Since listing on the New York Stock Exchange in 2020, Yatsen has prioritized R&D as a core growth driver. The company's cumulative R&D investment has surpassed 600 million yuan, with R&D spending accounting for more than 3 percent of revenue for three consecutive years — among the highest ratios in the global beauty sector.

The group has established three global R&D centers in Shanghai, Guangzhou, Guangdong province and Toulouse, France — supported by self-built factories that complete an "end-to-end" innovation chain from ingredient research to clinical validation and production. The Shanghai Global Innovation R&D Center, with an initial investment exceeding 80 million yuan, houses over 300 advanced instruments and serves as the group's scientific hub.

"Becoming a world-class pioneer in beauty innovation is not a slogan," Huang added. "It is the result of years of sustained investment and technological accumulation."